Elemance Revenue and Competitors

Clemmons, NC

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elemance's estimated annual revenue is currently $2.6M per year.(i)
  • Elemance's estimated revenue per employee is $155,000

Employee Data

  • Elemance has 17 Employees.(i)
  • Elemance grew their employee count by 6% last year.

Elemance's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
VP Engineering ServicesReveal Email/Phone
3
Project ManagerReveal Email/Phone
4
Sales & Licensing Manager, EngineerReveal Email/Phone
5
Senior EngineerReveal Email/Phone
6
Biomechanical EngineerReveal Email/Phone
7
Modeling EngineerReveal Email/Phone
8
Biomechanical EngineerReveal Email/Phone
9
Research EngineerReveal Email/Phone
10
Biomechanical EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M72-13%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
$0.9M11-39%N/AN/A
#6
$1.7M1110%N/AN/A
#7
$0.6M4-33%N/AN/A
#8
$4.8M31-6%N/AN/A
#9
$6.4M413%N/AN/A
#10
$4.2M27-18%N/AN/A
Add Company

What Is Elemance?

Elemance’s vision is to protect and improve human life by providing virtual human body model based tools and expertise to enable truly human centered design. Incorporated in 2014, Elemance is the exclusive distributor of the GHBMC models, to both commercial and academic users. We license the complete family of human body models, encompassing both male and female, a range of postures, and varying levels of complexity. In addition to licensing, Elemance provides comprehensive maintenance, enhancement and support of licensed models, as well as consulting services related to biomechanics, injury biomechanics, and other human modeling applications.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M18N/AN/A
#2
$6.5M300%N/A
#3
N/A3410%N/A
#4
$7.9M340%N/A
#5
$36M12413%N/A